Drug Discovery with Machine Learning

The output of an algorithm is only the beginning of the story. Kyle chats with Alexander Zhebrak, CTO of Insilico Medicine, Inc. Insilico self describes as artificial intelligence for drug discovery, biomarker development, and aging research.

Guest

Alexander Zhebrak: Alexander Zhebrak, CTO of Insilico Medicine, Inc

Drug Discovery with Machine Learning